(R)-6-(4-Aminophenyl)-5-Methyl-4,5-Dihydropyridazin-3(2H)-One (R)-6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2H)-哒嗪酮

CAS 101328-85-2 MFCD09032921

化学结构图

101328-85-2
SMILES: CC1CC(=O)NN=C1C1C=CC(N)=CC=1

化学属性

Mol. FormulaC11H13N3O
Mol. Weight203.244

别名和识别编码

Chemical Name(R)-6-(4-Aminophenyl)-5-Methyl-4,5-Dihydropyridazin-3(2H)-One
Chemical Name Translation(R)-6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2H)-哒嗪酮
InChIKeyGDMRFHZLKNYRRO-SSDOTTSWSA-N
LabNetwork Molecule IDLN01281785
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Mark P. Hehir, et al. 487: OR-1855, a levosimendan metabolite with an effect on human myometrial contractility.December 2009Volume 201, Issue 6, Supplement, Pages S182-S183.
  • [1]. Banfor PN, et al. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H238-48.
  • [1]. Banfor PN, et al. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H238-48.
  • [2]. Mark P. Hehir, et al. 487: OR-1855, a levosimendan metabolite with an effect on human myometrial contractility.December 2009Volume 201, Issue 6, Supplement, Pages S182-S183.

系列性分类

  1. Medical Research Areas
  2. Metabolism
  3. Phosphodiesterase (PDE)  (磷酸二酯酶)

相关产品推荐